# Cotwo Advisors Physical European Carbon Allowance Trust: financial statements, quarterly

CTWO · NYSE · CIK 1958928 · [Financials](/sectors/financials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/ctwo.md) · [Financials](/companies/ctwo/financials.md) · [Filings](/companies/ctwo/filings.md) · [Insiders](/companies/ctwo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ctwo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating income | $k | [(3.7)](/filings/0001213900-25-099117.md) | [(3.5)](/filings/0001213900-26-044130.md) | [(3.2)](/filings/0001213900-26-075156.md) | [(3.5)](/filings/0001213900-26-108305.md) |
| Net income | $k | [(0.0)](/filings/0001213900-25-099117.md) | [(299)](/filings/0001213900-26-044130.md) | [219](/filings/0001213900-26-075156.md) | [53.9](/filings/0001213900-26-108305.md) |
| Basic EPS | $ per share | [0.00](/filings/0001213900-25-099117.md) | [(2.99)](/filings/0001213900-26-044130.md) | [2.19](/filings/0001213900-26-075156.md) | [0.54](/filings/0001213900-26-108305.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | [20.5](/filings/0001213900-26-044130.md) | [16.8](/filings/0001213900-26-044130.md) | not reported | not reported |
| Total assets | $k | [2,541](/filings/0001213900-25-099117.md) | [1,921](/filings/0001213900-26-108305.md) | [1,622](/filings/0001213900-26-044130.md) | [1,841](/filings/0001213900-26-075156.md) | [1,895](/filings/0001213900-26-108305.md) |
| Total liabilities | $k | [1.7](/filings/0001213900-25-099117.md) | [1.2](/filings/0001213900-26-108305.md) | [1.1](/filings/0001213900-26-044130.md) | [1.2](/filings/0001213900-26-075156.md) | [1.3](/filings/0001213900-26-108305.md) |
| Shareholders' equity | $k | [2,539](/filings/0001213900-26-108305.md) | [1,920](/filings/0001213900-26-108305.md) | [1,621](/filings/0001213900-26-075156.md) | [1,840](/filings/0001213900-26-108305.md) | [1,894](/filings/0001213900-26-108305.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: |
| Operating cash flow | $ | [(3,681)](/filings/0001213900-26-044130.md) | [(3,062) d](/filings/0001213900-26-075156.md) | [5,496 d](/filings/0001213900-26-108305.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 100,000 at 2026-10-09, from the cover of the [10-Q filed 2026-10-09](/filings/0001213900-26-108305.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.